Literature DB >> 7809478

Molecular basis of colony morphology in Mycobacterium avium.

J T Belisle1, P J Brennan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7809478     DOI： 10.1016/0923-2508(94)90024-8

Source DB:  PubMed          Journal:  Res Microbiol        ISSN： 0923-2508            Impact factor:   3.992


× No keyword cloud information.
  12 in total

1.  A genetic mechanism for deletion of the ser2 gene cluster and formation of rough morphological variants of Mycobacterium avium.

Authors:  T M Eckstein; J M Inamine; M L Lambert; J T Belisle
Journal:  J Bacteriol       Date:  2000-11       Impact factor: 3.490

2.  Altered IL-1 expression and compartmentalization in monocytes from patients with AIDS stimulated with Mycobacterium avium complex.

Authors:  J L Johnson; H Shiratsuchi; Z Toossi; J J Ellner
Journal:  J Clin Immunol       Date:  1997-09       Impact factor: 8.317

3.  Growth, Congo Red agar colony morphotypes and antibiotic susceptibility testing of Mycobacterium avium subspecies paratuberculosis.

Authors:  Nicole M Parrish; Chiew G Ko; James D Dick; Paul B Jones; Jay L E Ellingson
Journal:  Clin Med Res       Date:  2004-05

4.  The two-component regulatory system mtrAB is required for morphotypic multidrug resistance in Mycobacterium avium.

Authors:  Gerard A Cangelosi; Julie S Do; Robert Freeman; John G Bennett; Makeda Semret; Marcel A Behr
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

5.  Immunomodulatory spectrum of lipids associated with Mycobacterium avium serovar 8.

Authors:  W W Barrow; T L Davis; E L Wright; V Labrousse; M Bachelet; N Rastogi
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

6.  Identification and recombinant expression of a Mycobacterium avium rhamnosyltransferase gene (rtfA) involved in glycopeptidolipid biosynthesis.

Authors:  T M Eckstein; F S Silbaq; D Chatterjee; N J Kelly; P J Brennan; J T Belisle
Journal:  J Bacteriol       Date:  1998-11       Impact factor: 3.490

7.  Most human isolates of Mycobacterium avium Mav-A and Mav-B are strong producers of hemolysin, a putative virulence factor.

Authors:  Laura Rindi; Daniela Bonanni; Nicoletta Lari; Carlo Garzelli
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

8.  Biofilm formation by Mycobacterium avium isolates originating from humans, swine and birds.

Authors:  Tone Bjordal Johansen; Angelika Agdestein; Ingrid Olsen; Sigrun Fredsvold Nilsen; Gudmund Holstad; Berit Djønne
Journal:  BMC Microbiol       Date:  2009-08-06       Impact factor: 3.605

9.  Identification of the surface-exposed lipids on the cell envelopes of Mycobacterium tuberculosis and other mycobacterial species.

Authors:  A Ortalo-Magné; A Lemassu; M A Lanéelle; F Bardou; G Silve; P Gounon; G Marchal; M Daffé
Journal:  J Bacteriol       Date:  1996-01       Impact factor: 3.490

10.  Potential drug targets for Mycobacterium avium defined by radiometric drug-inhibitor combination techniques.

Authors:  N Rastogi; K S Goh; E L Wright; W W Barrow
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.